Where does Biolitec Pharma Marketing Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biolitec Pharma Marketing Ltd ranks #15,859 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biolitec Pharma Marketing Ltd hold?

Biolitec Pharma Marketing Ltd holds 18 US utility patents granted between 2015 and 2016, spanning 11 technology areas.

What is Biolitec Pharma Marketing Ltd's Innovation Score?

Biolitec Pharma Marketing Ltd has an Innovation Score of 29.1 out of 100 (30th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biolitec Pharma Marketing Ltd focus on?

Biolitec Pharma Marketing Ltd's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 9 patents, ranking #2,395 of 7,163 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Biolitec Pharma Marketing Ltd's patent grant rate increasing or decreasing?

Biolitec Pharma Marketing Ltd's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biolitec Pharma Marketing Ltd's patents?

Biolitec Pharma Marketing Ltd's patents average 12.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biolitec Pharma Marketing Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biolitec Pharma Marketing Ltd

USPTO PatentsView assignee record - 18 granted patents across 11 technology areas, recorded in grant years 2015–2016. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biolitec ranks #15,859 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 11 technology areas.

#15,859
of 49,997 US assignees by volume: 30th percentile
by Innovation Score (29.1/100): 12.1
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15859 · Foreign Corporation #15,859 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #15,859/49,997
PHOTO-FINISH Bergen Teknologiover…
CPC-FOCUS A61K · 11 areas
INNOV-THIN 29.1/100
CLAIMS-RICH 12.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bergen Teknologioverføring AS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biolitec’s 29.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (35%) Velocity 0.0 pts (0%) Breadth 11.7 pts (40%) Claim depth 7.2 pts (25%)

Qualcomm Incorporated · highest

85
Biolitec Pharma… · this assignee

29
3D Lighting… · lowest

7

What this shows Biolitec's Innovation Score is 29.1/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biolitec?

Each dot is one of Biolitec’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biolitec’s own 12.1 claims/patent is at or below the 14.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Biolitec vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biolitec's grants concentrate

Biolitec Pharma Marketing Ltd is a focused PatentsView assignee: 11 CPC subclasses with 50% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (14 grants) versus a trough of 4 in 2016. By volume, Biolitec sits between Bergen Teknologioverføring AS and Brainscope Company, Inc..

Bergen Teknologio…

18
Berry Genetics

18
Binx Health

18
Biosplice Therape…

18
Black Diamond Equ…

18
Blue Coat Systems

18
Bohning

18
Brainscope

18
Biolitec Pharma M… ◀

18

What this shows Biolitec holds 18 patents at rank #15,867, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biolitec

By rank, the assignees closest to #15,867 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Biolitec's primary technology class.

Biolitec's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 30th percentile higher than 30% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2016

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biolitec Pharma Marketing Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	14	77.8%
2016	4	22.2%

Which technologies does Biolitec Pharma Marketing Ltd patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

A61B - DIAGNOSIS; SURGERY; Identification 7

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C07D - Heterocyclic Compounds 2

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

G02B - Optical Elements, Systems OR Apparatus 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biolitec Pharma Marketing Ltd's patent record in context - here's where to go next.

Biolitec Pharma Marketing Ltd's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 50% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #15,859 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biolitec Pharma Marketing Ltd against Bergen Teknologioverføring AS, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.